Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy
HEART
1 other identifier
observational
400
1 country
1
Brief Summary
Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy (HEART) is a single-center observational registry evaluating the heart of patients hospitalized for acute ischemic stroke with reperfusion therapy. This registry aims to establish quantified risk stratification and prognostic models, as well as suggest effective diagnostic and therapeutic strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2025
CompletedFirst Posted
Study publicly available on registry
March 18, 2025
CompletedStudy Start
First participant enrolled
March 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2029
ExpectedMay 13, 2025
March 1, 2025
1 year
March 10, 2025
May 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of Major Adverse Cardiovascular Events
cardiovascular mortality (any mortality due to ischemic stroke, myocardial infarction, other cardiac diseases, or unobserved sudden death), ischemic stroke, myocardial infarction and unstable angina
1 year
Secondary Outcomes (11)
Rate of Major Adverse Cardiovascular Events
90 days
Functional Outcome
90 days
Rate of Ischemic Stroke
1 year
Rate of Acute Coronary Syndrome
1 year
Rate of Cardiovascular Mortality
1 year
- +6 more secondary outcomes
Study Arms (1)
Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy
Acute ischemic stroke within 24 h after onset of stroke-related symptoms.
Interventions
observational only- no intervention
Eligibility Criteria
Acute ischemic stroke patients within 24 h after onset of stroke-related symptoms.
You may qualify if:
- Written informed consent by patient
- Age ≥ 18 years
- Acute ischemic stroke (with matching brain lesion on MR imaging)
- Enrolment within 24 h after onset of stroke-related symptoms.
You may not qualify if:
- Pregnancy and / or breast-feeding.
- Participation in an interventional study.
- Patients refuse to participate in the research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The first affiliated hospital of soochow university
Suzhou, Jiangsu, 215000, China
Biospecimen
anticoagulant peripheral blood, serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
March 10, 2025
First Posted
March 18, 2025
Study Start
March 31, 2025
Primary Completion
March 31, 2026
Study Completion (Estimated)
March 31, 2029
Last Updated
May 13, 2025
Record last verified: 2025-03